表 2. Transmitted drug resistance and mutation sites in 25 HIV/AIDS patients.

25例HIV/AIDS患者传播性耐药及突变位点

Subject	Genotype	Protease inhibitor resistance mutations	ATV/r	DRV/r	LPV/r	NNRTI resistance mutations	EFV	ETR	NVP	RPV
S: Susceptible; P: Potential low-level resistance; L: Low-level resistance; I: Intermediate resistance; H: High-level resistance; PI: Protease inhibitor; ATV/r: Atazanavir/ritonavir; DRV/r: Darunavir/ritonavir; LPV/r: Lopinavir/ritonavir; NNRTI: Non-nucleoside reverse transcriptase inhibitors; EFV: Efavirenz; ETR: Etravirine; NVP: Nevirapine; RPV: Rilpivirine.
1	CRF01_AE	M46I	P	S	P		S	S	S	S
2	CRF01_AE		S	S	S	G190A	I	P	H	L
3	CRF01_AE		S	S	S	V106M, Y188D	H	S	H	S
4	CRF01_AE		S	S	S	E138G, V179E	L	L	L	L
5	CRF55_01B		S	S	S	E138G, V179E	L	L	L	L
6	-		S	S	S	E138A	S	P	S	L
7	CRF01_AE		S	S	S	V179D	P	P	P	P
8	CRF01_AE		S	S	S	V179D	P	P	P	P
9	CRF01_AE		S	S	S	V179VD	P	P	P	P
10	CRF01_AE		S	S	S	V106M	S	P	P	P
11	CRF01_AE		S	S	S	V179D	P	P	P	P
12	CRF01_AE		S	S	S	V179D	P	P	P	P
13	CRF01_AE		S	S	S	V179E	P	P	P	P
14	CRF01_AE		S	S	S	V179E	P	P	P	P
15	CRF07_BC		S	S	S	V106A	S	P	P	P
16	CRF07_BC		S	S	S	V179D	P	P	P	P
17	CRF07_BC		S	S	S	V179D	P	P	P	P
18	CRF07_BC		S	S	S	V179E	P	P	P	P
19	CRF07_BC		S	S	S	V179D	P	P	P	P
20	CRF07_BC		S	S	S	V179D	P	P	P	P
21	CRF08_BC		S	S	S	V179D	P	P	P	P
22	CRF55_01B		S	S	S	V179E	P	P	P	P
23	CRF67_01B		S	S	S	V179D	P	P	P	P
24	B		S	S	S	V106A	S	P	P	P
25	−		S	S	S	V179D	P	P	P	P